Uptake and antitumoral effects of iodine and 6-iodolactone in differentiated and undifferentiated human prostate cancer cell lines

Prostate

Volumn 73, Issue 1, 2013, Pages 31-41

  Aranda, Nuri ^a   Sosa, Susana ^a   Delgado, Guadalupe ^a   Aceves, Carmen ^a   Anguiano, Brenda ^a  

^a INSTITUTO DE NEUROBIOLOGÍA   (Mexico)

Author keywords

apoptosis; DU 145; LNCaP; proliferation; RWPE 1

Indexed keywords

6 IODOLACTONE; CASPASE 3; IODIDE; IODINE; LACTONE DERIVATIVE; PROTEIN BAX; PROTEIN BCL 2; SODIUM IODIDE SYMPORTER; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CANCER MODEL; CELL PROLIFERATION; CONTROLLED STUDY; DOSE RESPONSE; DRUG UPTAKE; ENZYME ASSAY; ENZYME IMMUNOASSAY; FLUORESCENCE ANALYSIS; HUMAN; HUMAN CELL; MITOSIS INHIBITION; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; NUDE MOUSE; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

ADENOCARCINOMA; ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; ARACHIDONIC ACIDS; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SCREENING ASSAYS, ANTITUMOR; GENE EXPRESSION; HUMANS; IODINE; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; PROSTATE; PROSTATIC NEOPLASMS;

EID: 84870501536     PISSN: 02704137     EISSN: 10970045     Source Type: Journal    
DOI: 10.1002/pros.22536     Document Type: Article

References (50)

1. Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin 2010;60:277300.
2. Andreoiu M, Cheng L. Multifocal prostate cancer: Biologic, prognostic, and therapeutic implications. Hum Pathol 2010;41: 781793.
3. Smyth PP. The thyroid, iodine and breast cancer. Breast Cancer Res 2003;5:235238.
4. Aceves C, Anguiano B. Is iodine an antioxidant and antiproliferative agent for the mammary and prostate glands? In: Preedy VR, Burrow GN, Watson RR, editors. Handbook of iodine. San Diego, California: Elsevier; 2009. pp. 249-257.
5. Liu XH, Chen GG, Vlantis AC, van Hasselt CA. Iodine mediated mechanisms and thyroid carcinoma. Crit Rev Clin Lab Sci 2009;46:302318.
6. Taurog AM. Hormone synthesis: Thyroid iodine metabolism. In: Braverman LE, Utiger R, editors. The thyroid. A fundamental and clinical text. Philadelphia, Lippincont: Williams and Wilkins; 2000. pp. 6184.
7. Thrall KD, Bull RJ. Differences in the distribution of iodine and iodide in the Sprague-Dawley rat. Fundam Appl Toxicol 1990; 15:7581.
8. Anguiano B, Garcia-Solis P, Delgado G, Aceves VC. Uptake and gene expression with antitumoral doses of iodine in thyroid and mammary gland: Evidence that chronic administration has no harmful effects. Thyroid 2007;17:851859.
9. Dohan O, De la Vieja, Paroder V, Riedel C, Artani M, Reed M, Ginter CS, Carrasco N. The sodium/iodide Symporter (NIS): Characterization, regulation, and medical significance. Endocr Rev 2003;24:4877.
10. Bizhanova A, Kopp P. The sodium-iodide symporter NIS and pendrin in iodide homeostasis of the thyroid. Endocrinology 2009;150:10841090.
11. Arroyo-Helguera O, Anguiano B, Delgado G, Aceves C. Uptake and antiproliferative effect of molecular iodine in the MCF-7 breast cancer cell line. Endocr Relat Cancer 2006;13: 11471158.
12. Küpper FC, Schweigert N, Ar Gall E, Legendre JM, Vilter H, Kloareg B. Iodine uptake in Laminariales involves extracellular, haloperoxidase-mediated oxidation of iodide. Planta 1998;207:163171.
13. Smerdely P, Pitsiavas V, Boyages SC. Evidence that the inhibitory effects of iodide on thyroid cell proliferation are due to arrest of the cell cycle at G0G1 and G2M phases. Endocrinology 1993;133:28812888.
14. Vitale M, Di Matola, DAscoli F, Salzano S, Bogazzi F, Fenzi G, Martino E, Rossi G. Iodide excess induces apoptosis in thyroid cells through a p53-independent mechanism involving oxidative stress. Endocrinology 2000;141:598605.
15. Dijkstra B, Prichard RS, Lee A, Kelly LM, Smyth PP, Crotty T, McDermott EW, Hill AD, OHiggins N. Changing patterns of thyroid carcinoma. Ir J Med Sci 2007;176:8790.
16. Maier J, van SH, van OC, Paschke R, Weiss RE, Krohn K. Iodine deficiency activates antioxidant genes and causes DNA damage in the thyroid gland of rats and mice. Biochim Biophys Acta 2007;1773:990999.
17. Liu XH, Chen GG, Vlantis AC, Tse GM, van Hasselt CA. Iodine induces apoptosis via regulating MAPKs-related p53, p21, and Bcl-xL in thyroid cancer cells. Mol Cell Endocrinol 2010; 320:128135.
18. Garcia-Solis P, Alfaro Y, Anguiano B, Delgado G, Guzman RC, Nandi S, Diaz-Munoz M, Vazquez-Martinez O, Aceves C. Inhibition of N-methyl-N- nitrosourea-induced mammary carcinogenesis by molecular iodine (I2) but not by iodide (I-) treatment Evidence that I2 prevents cancer promotion. Mol Cell Endocrinol 2005;236:4957.
19. Aceves C, Garcia-Solis P, Arroyo-Helguera O, Vega-Riveroll L, Delgado G, Anguiano B. Antineoplastic effect of iodine in mammary cancer: Participation of 6-iodolactone (6-IL) and peroxisome proliferator-activated receptors (PPAR). Mol Cancer 2009;8:33.
20. Shrivastava A, Tiwari M, Sinha RA, Kumar A, Balapure AK, Bajpai VK, Sharma R, Mitra K, Tandon A, Godbole MM. Molecular iodine induces caspase-independent apoptosis in human breast carcinoma cells involving the mitochondriamediated pathway. J Biol Chem 2006;281:1976219771.
21. Stoddard FR, Brooks AD, Eskin BA, Johannes GJ. Iodine alters gene expression in the MCF7 breast cancer cell line: Evidence for an anti-estrogen effect of iodine. Int J Med Sci 2008;5:189 196.
22. Thomasz L, Oglio R, Dagrosa MA, Krawiec L, Pisarev MA, Juvenal GJ. 6 Iodo-delta-lactone reproduces many but not all the effects of iodide. Mol Cell Endocrinol 2010;323:161166.
23. Soriano O, Delgado G, Anguiano B, Petrosyan P, Molina-Serv?́n ED, Gonsebatt ME, Aceves C. Antineoplastic effect of iodine and iodide in dimethylbenz[a]anthracene-induced mammary tumors: Association between lactoperoxidase and estrogenadduct production. Endocr Relat Cancer 2011;18:529539.
24. Arroyo-Helguera O, Rojas E, Delgado G, Aceves C. Signaling pathways involved in the antiproliferative effect of molecular iodine in normal and tumoral breast cells: Evidence that 6- iodolactone mediates apoptotic effects. Endocr Relat Cancer 2008;15:10031011.
25. Hoption Cann SA, Qiu Z, van NC. A prospective study of iodine status, thyroid function, and prostate cancer risk: Follow- up of the First National Health and Nutrition Examination Survey. Nutr Cancer 2007;58:2834.
26. Spitzweg C, Joba W, Eisenmenger W, Heufelder AE. Analysis of human sodium iodide symporter gene expression in extrathyroidal tissues and cloning of its complementary deoxyribonucleic acids from salivary gland, mammary gland, and gastric mucosa. J Clin Endocrinol Metab 1998;83:17461751.
27. Lacroix L, Mian C, Caillou B, Talbot M, Filetti S, Schlumberger M, Bidart JM. Na(p)/I(-) symporter and Pendred syndrome gene and protein expressions in human extra-thyroidal tissues. Eur J Endocrinol 2001;144:297302.
28. Perron B, Rodriguez AM, Leblanc G, Pourcher T. Cloning of the mouse sodium iodide symporter and its expression in the mammary gland and other tissues. J Endocrinol 2001;170:185196.
29. Wapnir IL, van de Rijn M, Nowels K, Amenta PS, Walton K, Montgomery K, Greco RS, Dohan O, Carrasco N. Immunohistochemical profile of the sodium/iodide symporter in thyroid, breast, and other carcinomas using high density tissue microarrays and conventional sections. J Clin Endocrinol Metab 2003;88:18801888.
30. Navarra M, Micali S, Lepore SM, Cesinaro AM, Celano M, Sighinolfi MC, De GC, Filetti S, Bianchi G, Russo D. Expression of the sodium/iodide symporter in human prostate adenocarcinoma. Urology 2010;75:773778.
31. McAlpine RK. The rate of oxidation of iodide ion by hydrogen peroxide. J Chem Educ 1945;22:387390.
32. Tennant JR. Evaluation of the trypan blue technique for determination of cell viability. Transplantation 1964;2:685694.
33. Kogai T, Taki K, Brent GA. Enhancement of sodium/iodide symporter expression in thyroid and breast cancer. Endocr Relat Cancer 2006;13:797826.
34. Altorjay A, Dohan O, Szilagyi A, Paroder M, Wapnir IL, Carrasco N. Expression of the Na/I- symporter (NIS) is markedly decreased or absent in gastric cancer and intestinal metaplastic mucosa of Barrett esophagus. BMC Cancer 2007;7:5.
35. Spitzweg C, Scholz IV, Bergert ER, Tindall DJ, Young CY, Goke B, Morris JC. Retinoic acid-induced stimulation of sodium iodide symporter expression and cytotoxicity of radioiodine in prostate cancer cells. Endocrinology 2003;144:34233432.
36. Rillema JA, Hill MA. Pendrin transporter carries out iodide uptake into MCF-7 human mammary cancer cells. Exp Biol Med 2003;228:10781082.
37. Rosner H, Torremante P, Moller W, Gartner R. Antiproliferative/ cytotoxic activity of molecular iodine and iodolactones in various human carcinoma cell lines. No interfering with EGFsignaling, but evidence for apoptosis. Exp Clin Endocrinol Diabetes 2010;118:410419.
38. Nomura Y, Bhawal UK, Nishikiori R, Sawajiri M, Maeda T, Okazaki M. Effects of high-dose major components in oral disinfectants on the cell cycle and apoptosis in primary human gingival fibroblasts in vitro. Dent Mater J 2010;29:7583.
39. Roumeguère T, Delree P, Van Antwerpen P, Rorive S, Vanhamme L, de Ryhove LD, Serteyn D, Wespes E, Vanhaerverbeek M, Boudjeltia KZ. Intriguing location of myeloperoxidase in the prostate: A preliminary immunohistochemical study. Prostate 2011;72:507513. DOI: 10.1002/pros.21452:
40. Marks LS, Kojima M, Demarzo A, Heber D, Bostwick DG, Qian J, Dorey FJ, Veltri RW, Mohler JL, Partin AW. Prostate cancer in native Japanese and Japanese-American men: Effects of dietary differences on prostatic tissue. Urology 2004;64:765771.
41. Fiore AP, Fuziwara CS, Kimura ET. High iodine concentration attenuates RET/PTC3 oncogene activation in thyroid follicular cells. Thyroid 2009;19:12491256.
42. Dugrillon A, Uedelhoven WM, Pisarev MA, Bechtner G, Gartner R. Identification of delta-iodolactone in iodide treated human goiter and its inhibitory effect on proliferation of human thyroid follicles. Horm Metab Res 1994;26:465469.
43. Gartner R, Rank P, Ander B. The role of iodine and delta-iodolactone in growth and apoptosis of malignant thyroid epithelial cells and breast cancer cells. Hormones 2010;9:6066.
44. Nuñez-Anita RE, Arroyo-Helguera O, Cajero-Juarez M, Lopez- Bojorquez L, Aceves C. A complex between 6-iodolactone and the peroxisome proliferator-activated receptor type gamma may mediate the antineoplastic effect of iodine in mammary cancer. Prostaglandins Other Lipid Mediat 2009; 89:3442.
45. Dahiya R, Boyle B, Goldberg BC, Yoon WH, Konety B, Chen K, Yen TS, Blumenfeld W, Narayan P. Metastasis-associated alterations in phospholipids and fatty acids of human prostatic adenocarcinoma cell lines. Biochem Cell Biol 1992;70:548554.
46. Faas FH, Dang AQ, Pollard M, Hong XM, Fan K, Luckert PH, Schutz M. Increased phospholipid fatty acid remodeling in human and rat prostatic adenocarcinoma tissues. J Urol 1996; 156:243248.
47. Nuñez-Anita RE, Cajero-Juárez M, Aceves C. Peroxisome proliferator- activated receptors. role of isoform gamma in the antineoplastic effect of iodine in mammary cancer. Curr Cancer Drug Targets 2011;11:775786.
48. Joanta AE, Filip A, Clichici S, Andrei S, Daicoviciu D. Iodide excess exerts oxidative stress in some target tissues of the thyroid hormones. Acta Physiol Hung 2006;93:347359.
49. Nyska A, Lomnitski L, Maronpot R, Moomaw C, Brodsky B, Sintov A, Wormser U. Effects of iodine on inducible nitric oxide synthase and cyclooxygenase-2 expression in sulfur mustard- induced skin. Arch Toxicol 2001;74:768774.
50. Clapp CH, McKown J, Xu H, Grandizio AM, Yang G, Fayer J. The action of soybean lipoxygenase-1 on 12-iodo-cis-9-octadecenoic acid: The importance of C11-H bond breaking. Biochemistry 2000;39:26032611.